Pharmacist Independent Prescriber, Boots UK
Ruth Campbell’s background is in community pharmacy, where she has worked for Boots Pharmacy since 2000. Qualifying as a prescriber in 2006, Ruth developed her first clinic and established her own pharmacist-led chronic disease clinic for Atrial Fibrillation patients, for which she won the UK Pharma award of Community Pharmacist of the Year in 2007 and the Scottish Chemist Review award for Pharmaceutical Care the same year. Ruth has since broadened her Independent Prescribing experience, extending to other additional clinical areas including contraception, polypharmacy review for Care Home patients, Unscheduled Care. She has also established a clinic for unpaid carers. Ruth continues to practice in community pharmacy in addition to the above prescribing work and now also works in primary care pharmacy as one of two NHS Lanarkshire Medicines Management Pharmacists for Care at Home, a role held for over 5 years.
‘An Independent Prescriber’s Experience - Person-centred Polypharmacy medication review within the Care Homes setting’
With over 6 years’ experience of polypharmacy medication review within the Care Homes setting, Ruth is a community pharmacist currently working with two Care Homes in Hamilton, Lanarkshire to provide Pharmacist Independent Prescriber polypharmacy review clinics for their residents. Care Home patients are represented in one of the commitments of the Scottish Government’s 2017 publication ‘Achieving Excellence in Pharmaceutical Care’. In addition, the 2018 Polypharmacy Guidance ‘Realistic Prescribing’ highlights this patient group within its criteria to prioritise patients for polypharmacy review. With frailty, high risk medicines and end of life care as common themes, Ruth uses the 7 steps medication review model to achieve appropriate polypharmacy during the annual medication reviews she undertakes for her Care Homes patients. Working with GPs, nurses, carers, families, CPNs and others, Ruth implements and communicates her prescription changes to support timely interventions, improving pharmaceutical care of this patient population.